| Literature DB >> 36081587 |
Arbănași Emil-Marian1, Kaller Reka1, Mureșan Vasile Adrian1,2, Voidăzan Septimiu3, Arbănași Eliza-Mihaela4, Russu Eliza1,2.
Abstract
The COVID-19 outbreak has placed substantial pressure on the medical systems worldwide. This study aimed to investigate the influence of the prepandemic vs. pandemic period on the activity of the Vascular Surgery Unit of a large emergency hospital in Eastern Europe. We performed a retrospective review of the vascular surgery cases admitted, comparing the statistics from the two time periods. We examined data of a total of 1,693 patients over the two periods. We report a 34.51% decrease in the surgical procedures performed during the pandemic period, with a disproportionate 80.6% decrease in the number of cases admitted with a diagnosis of venous insufficiency diagnosis and an increase of 67.21% in the number of patients admitted with acute arterial ischemia. Furthermore, individuals not classed as emergencies were delayed or denied surgical care. The number of nonurgent procedures conducted by our Vascular Surgery Unit decreased significantly, whereas the number of emergency surgeries increased. COVID-19's effect is projected to have a long-term impact on how surgical treatments are provided in Romania.Entities:
Keywords: COVID-19; pandemic; public health; surgical activity; vascular surgery
Year: 2022 PMID: 36081587 PMCID: PMC9445812 DOI: 10.3389/fsurg.2022.883935
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Evolution of the number of patients newly diagnosed with COVID-19 in Romania (6).
Pathologies and basic characteristics for the prepandemic and the pandemic periods.
| Prepandemic 1 June 2018–30 November 2019 | Pandemic 1 June 2020–30 November 2021 | Difference (%) | ||
|---|---|---|---|---|
| CVI | 134 (13.1%) | 26 (3.88%) | −9.22 | <0.0001 |
| ESKD | 87 (8.5%) | 61 (9.1%) | 0.60 | 0.66 |
| PAD | 653 (63.83%) | 342 (51.04%) | −12.79 | <0.0001 |
| STG II A Fontaine | 114 (11.14%) | — | −11.14 | 0.0003 |
| STG II B Fontaine | 182 (17.79%) | 57 (8.51%) | −9.28 | <0.0001 |
| STG III Fontaine | 193 (18.87%) | 123 (18.36%) | −0.51 | 0.79 |
| STG IV Fontaine | 164 (16.03%) | 162 (24.18%) | 8.15 | <0.0001 |
| Critical limb ischemia | 357 (34.90% | 285 (42.54%) | 7.64 | 0.001 |
| Symptomatic carotid stenosis | 69 (6.74%) | 100 (14.93%) | 8.18 | <0.0001 |
| ALI | 61 (5.96%) | 102 (15.22%) | 9.26 | <0.0001 |
| Other pathology | 19 (1.86%) | 39 (5.82%) | 3.96 | <0.0001 |
| All patient | 1023 | 670 | −34.51 | — |
| Mures-county no. (%) | 579 (56.59%) | 488 (72.83%) | — | 0.0003 |
| Other county no. (%) | 444 (43.41%) | 182 (27.17%) | — | |
| Age mean ± SD, (min–max) | 66.49 ± 11.03 (20–93) | 66.47 ± 10.85 (19–98) | — | 0.96 |
| Sex (M/F) | 72.43%/27.57% | 74.63%/25.37% | — | 0.34 |
| Duration of hospital stay (days), median [interquartile range] | 8 [4–12] | 7 [4–11] | — | 0.07 |
CVI, chronic venous insufficiency; ESKD, end-stage kidney disease; PAD, peripheral arterial disease; STG, stage; ALI, acute limb ischemia; SD, standard deviation.
Chi-square test.
Student’s t-test.
Mann–Whitney test.
Characteristics of pandemic period patients.
| Variables | Non-COVID-19 patients ( | COVID-19 patients ( | |
|---|---|---|---|
| CVI | 26 (4.92%) | — | 0.058 |
| ESKD | 61 (11.55%) | — | 0.01 |
| Symptomatic carotid stenosis | 79 (14.96%) | 21 (14.78%) | 0.95 |
| Acute limb ischemia | 58 (10.98%) | 44 (30.98%) | <0.0001 |
| Other pathology | 30 (5.68%) | 9 (6.33%) | 0.76 |
| Peripheral arterial disease | |||
| Suprainguinal revascularization | 70 (13.25%) | 18 (12.67%) | 0.85 |
| Infrainguinal revascularization | 103 (19.50%) | 23 (16.19%) | 0.37 |
| Amputation | 54 (10.22%) | 36 (25.35%) | <0.0001 |
| Endovascular treatment | 38 (7.19%) | — | 0.02 |
| Age mean ± SD (min–max) | 65.75 ± 12.17 (19–98) | 67.19 ± 11.46 (36–84) | 0.33 |
| Sex (M/F) | 79.35%/20.65% | 57.04%/42.96% | <0.0001 |
| Duration of hospital stay (days), median [interquartile range] | 6 [4–9] | 8 [7–11] | 0.001 |
| ICU admission, no. (%) | 135 (25.56%) | 68 (47.88%) | <0.0001 |
| Deaths, no. (%) | 77 (14.58%) | 45 (31.69%) | <0.0001 |
CVI, chronic venous insufficiency; ESKD, end-stage kidney disease; ICU, intensive care unit; SD, standard deviation.
Chi-square test.
Student’s t-test.
Mann–Whitney test.
Types of surgeries and their characteristics for both periods—part I.
| Prepandemic 1 June 2018–30 November 2019 | Pandemic 1 June 2020–30 November 2021 | Difference (%) | ||
|---|---|---|---|---|
| Chronic venous insufficiency | ||||
| Venous stripping | 96 (71.64%) | 21 (80.76%) | 9.12 | 0.34 |
| Radiofrequency ablation | 38 (28.36%) | 5 (19.24%) | −9.12 | |
| Age mean ± SD (min–max) | 55.14 ± 13.95 (20–83) | 55.26 ± 16.98 (19–75) | — | 0.97 |
| Sex (M/F) | 43.28%/56.72% | 38.46%/61.54% | — | 0.81 |
| Duration of hospital stay (days), median [interquartile range] | 3 [2–4] | 3 [2.25–4] | — | 0.36 |
| End-stage kidney disease | ||||
| rc-avf | 41 (47.12%) | 29 (47.54%) | 0.42 | 0.96 |
| bc-avf | 30 (34.48%) | 22 (36.06%) | 1.58 | 0.84 |
| bb-avf | 16 (6.89%) | 10 (16.39%) | 9.5 | 0.75 |
| Age mean ± SD (min–max) | 67.5 ± 10.53 (36–89) | 65.16 ± 13.53 (31–91) | — | 0.26 |
| Sex (M/F) | 66.67%/33.33% | 63.93%/36.07% | — | 0.54 |
| Duration of hospital stay (days), median [interquartile range] | 2 [2–2] | 2 [2–2] | — | 0.27 |
| Symptomatic carotid stenosis | ||||
| Carotid endarterectomy | 69 (6.74%) | 100 (14.93%) | 8.18 | <0.0001 |
| Age mean ± SD (min–max) | 69.69 ± 7.58 (58–83) | 65.65 ± 8.87 (37–82) | — | <0.001 |
| Sex (M/F) | 63.76%/36.24% | 70%/30% | — | 0.49 |
| Duration of hospital stay (days), median [interquartile range] | 5 [4–7] | 4 [3–4] | — | <0.0001 |
| Acute limb ischemia | ||||
| Upper limb embolectomy | 14 (22.95%) | 32 (31.37%) | 8.42 | 0.24 |
| Lower limb embolectomy | 47 (77.05%) | 70 (68.63%) | −8.42 | |
| Age mean ± SD (min–max) | 67.22 ± 7.06 (54–88) | 68.53 ± 12.21 (31–91) | — | 0.38 |
| Sex (M/F) | 83.61%/16.39% | 74.51%/25.49% | — | 0.24 |
| Duration of hospital stay (days), median [interquartile range] | 11 [8–14] | 8 [5–12] | — | 0.01 |
RC-AVF, radial-cephalic arteriovenous fistula; BC-AVF, brachial-cephalic arteriovenous fistula; BB-AVF, brachio-basilic arteriovenous fistula; SD, standard deviation.
Student’s t-test.
Chi-square test.
Mann–Whitney test.
Types of surgeries and their characteristics for both periods—part II.
| Prepandemic 1 June 2018–30 November 2019 | Pandemic 1 June 2020–30 November 2021 | Difference (%) | ||
|---|---|---|---|---|
| Suprainguinal revascularization | ||||
| Ilio-femoral by-pass | 52 (32.91%) | 32 (36.36%) | 3.45 | 0.60 |
| Aorto-femoral by-pass | 50 (31.65%) | 32 (36.36%) | 4.72 | 0.45 |
| Aorto-bifemoral by-pass | 56 (35.44%) | 24 (27.27%) | −8.17 | 0.19 |
| Age mean ± SD (min–max) | 67.14 ± 8.54 (45–87) | 65.59 ± 7.7 (47–82) | — | 0.14 |
| Sex (M/F) | 79.74%/20.26% | 81.81%/18.19% | — | 0.82 |
| Duration of hospital stay (days), median [interquartile range] | 11.5 [8–14] | 9 [7–11.5] | — | <0.0001 |
| Infrainguinal revascularization | ||||
| FP bypass with saphenous vein | 28 (8.78%) | 19 (15.07%) | 6.30 | 0.054 |
| FP bypass with grafts | 230 (72.10%) | 90 (71.43%) | −0.67 | −0.88 |
| Remote endarterectomy | 61 (19.12%) | 17 (13.49%) | −5.63 | 0.16 |
| Age mean ± SD (min–max) | 68.77 ± 8.95 (30–93) | 68.13 ± 8.63 (36–91) | — | 0.48 |
| Sex (M/F) | 81.81%/18.19% | 85.71%/14.29% | — | 0.37 |
| Duration of hospital stay (days), median [interquartile range] | 10 [7–14] | 7 [6–10] | — | <0.0001 |
| Amputation | ||||
| AKA | 33 (53.23%) | 47 (52.23%) | −1 | 0.90 |
| BKA | 29 (46.77%) | 43 (47.77%) | 1 | |
| Age mean ± SD (min–max) | 68.19 ± 9.05 (36–91) | 70.71 ± 9.75 (47–91) | — | 0.1 |
| Sex (M/F) | 77.41%/22.59% | 76.66%/23.34% | — | 0.92 |
| Duration of hospital stay (days), median [interquartile range] | 8.5 [6–11] | 11.5 [7–11] | — | 0.001 |
| Endovascular treatment | ||||
| Balloon angioplasty | 74 (64.91%) | 21 (55.26%) | −9.65 | 0.28 |
| Stenting | 40 (35.09%) | 17 (44.74%) | 9.65 | |
| Age mean ± SD (min–max) | 66.42 ± 11.25 (32–88) | 60.55 ± 15.46 (19–84) | — | 0.03 |
| Sex (M/F) | 77.19%/22.81% | 63.15%/36.86% | — | 0.13 |
| Duration of hospital stay (days), median [interquartile range] | 9 [5–13] | 5.5 [4–8] | — | <0.0001 |
FP, femoral-popliteal; SD, standard deviation; AKA, above-knee amputation; BKA, below-knee amputation.
Student’s t-test.
Chi-square test.
Mann–Whitney test.
Hospital admissions/month pandemic/prepandemic.
| Prepandemic 2018 | Pandemic 2020 | Difference (%) | Pandemic peaks | |
|---|---|---|---|---|
| June | 73 | 56 | −23.29 | |
| July | 64 | 53 | −17.19 | |
| August | 65 | 50 | −23.08 | |
| September | 67 | 51 | −23.88 | |
| October | 54 | 49 | −9.26 | |
| November | 66 | 28 | −57.58 | First peak |
| December | 42 | 10 | −76.19 | |
| 2019 | 2021 | |||
| January | 68 | 52 | −23.53 | |
| February | 59 | 24 | −59.32 | |
| March | 55 | 43 | −21.82 | Second peak |
| April | 36 | 31 | −13.89 | |
| May | 39 | 39 | — | |
| June | 58 | 40 | −31 | |
| July | 48 | 34 | −29.17 | |
| August | 48 | 38 | −20.83 | |
| September | 61 | 22 | −63.93 | |
| October | 51 | 32 | −37.25 | Third peak |
| November | 69 | 18 | −73.91 |
January–December, the months of the year.